Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
DGRO vs XLV: how they differ
DGRO and XLV hold 16% of their weight in the same names, and XLV returned more over the year.
iShares Core Dividend Growth ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, DGRO and XLV hold 16% of their money in the same securities at the same weight.
| Holding | DGRO | XLV |
|---|---|---|
| JOHNSON & JOHNSON | 2.64% | 10.67% |
| ABBVIE INC | 2.53% | 7.76% |
| UNITEDHEALTH GROUP INC | 2.32% | 6.59% |
| MERCK & COMPANY INC | 1.75% | 5.54% |
| ELI LILLY & COMPANY | 1.14% | 16.56% |
| AMGEN INC | 1.11% | 3.41% |
| ABBOTT LABORATORIES | 0.79% | 2.76% |
| GILEAD SCIENCES INC | 0.78% | 2.74% |
| ELEVANCE HEALTH INC | 0.45% | 1.47% |
| CIGNA GROUP (THE) | 0.38% | 1.27% |
| STRYKER CORP | 0.24% | 1.90% |
| BECTON DICKINSON & COMPANY | 0.24% | 0.73% |
| Only in DGRO | Only in XLV |
|---|---|
| BROADCOM INC 3.25% | Intuitive Surgical Inc 2.46% |
| JP MORGAN CHASE & COMPANY 3.05% | Pfizer Inc 2.40% |
| APPLE INC 2.94% | CVS Health Corp 2.30% |
| MICROSOFT CORP 2.92% | Vertex Pharmaceuticals Inc 2.20% |
| EXXON MOBIL CORP 2.91% | Bristol-Myers Squibb Co 2.05% |
| PROCTER & GAMBLE COMPANY (THE) 2.08% | Medtronic PLC 1.75% |
| PHILIP MORRIS INTERNATIONAL INC 1.94% | Boston Scientific Corp 1.11% |
| HOME DEPOT INC (THE) 1.90% | Regeneron Pharmaceuticals Inc 1.09% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.
| DGRO iShares Core Dividend Growth ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | Core Dividend Growth | Health care |
| Total return, 1 year | +17.4% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −0.1 pts | +2.9 pts |
| Expense ratio | 0.08% | 0.08% |
| Already in the S&P 500 | 94.7% | 100.0% |
| Holdings | 394 | 59 |
DGRO in plain words
DGRO is an index equity fund tracking the Core Dividend Growth. Over the year to Sep 11, 2026 it returned +17.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Apr 30, 2026, 95% of the fund by weight is stocks the S&P 500 also holds, across 394 positions, with the top ten at 26.6%.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, DGRO or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, DGRO returned +17.4% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, DGRO or XLV?
- DGRO charges 0.08% a year and XLV charges 0.08%, so DGRO is cheaper. Fees come from each fund's prospectus.
- How much do DGRO and XLV overlap with the S&P 500?
- By their latest filed holdings, 95% of DGRO and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 16% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, DGRO against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/DGRO-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources